NAVIDEA BIOPHARMACEUTICALS I (NAVB) Earnings History & Surprises

NYSEARCA:NAVB • US63937X2027

Current stock price

0.0779 USD
0 (-2.99%)
Last:

NAVB Earnings overview

Past quarterly earnings results for NAVIDEA BIOPHARMACEUTICALS I (NAVB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 13, 2023

Last Reported

Most Recent
Release Date
Aug 11, 2023
Period
Q2 / 2023
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2023 - - - -100.00%
Q1 2023 - - - -
Q4 2022 -0.11 - 8.33% 610 - -98.79%
Q3 2022 -0.25 - -212.50% 7.52K - -92.20%
Q2 2022 -0.10 - -11.11% 57.53K - -77.96%
Q1 2022 -0.10 - 9.09% - -100.00%
Q4 2021 -0.12 - -9.09% 50.35K - -77.04%
Q3 2021 -0.08 -0.11 28.70% 38.46% 96.38K - -64.09%
Q2 2021 -0.09 -0.08 -10.29% 18.18% 261.05K 612K -57.34% -3.71%
Q1 2021 -0.11 -0.08 -34.80% 15.38% 123.74K 612K -79.78% -20.82%
Q4 2020 -0.11 -0.12 10.13% - 219.25K 612K -64.17% -
Q3 2020 -0.13 -0.09 -41.61% - 268.39K 153K 75.42% -
Q2 2020 -0.11 -0.12 10.13% - 271.1K 306K -11.41% -
Q1 2020 -0.13 - - 156.27K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NAVB EPS Q2Q GrowthNAVB EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 -50 -100 -150 -200

Revenue Historical Q2Q growth and Acceleration

NAVB Revenue Q2Q GrowthNAVB Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q2/23 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

NAVB Overview NAVB Technical Analysis Report NAVB Fundamental Analysis Report NAVB Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

NAVIDEA BIOPHARMACEUTICALS I / NAVB Earnings FAQ

What is the most recent earnings date for NAVB stock?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) last reported earnings on 8/11/2023.

Did NAVIDEA BIOPHARMACEUTICALS I (NAVB) beat earnings estimates last quarter?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) missed EPS estimates and missed revenue estimates in the most recent quarter.